These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11994323)

  • 1. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.
    Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A
    J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol, Cushing's Syndrome, and a shrinking brain-new evidence for reversibility.
    McEwen BS
    J Clin Endocrinol Metab; 2002 May; 87(5):1947-8. PubMed ID: 11994322
    [No Abstract]   [Full Text] [Related]  

  • 3. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.
    Dorn LD; Burgess ES; Friedman TC; Dubbert B; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Mar; 82(3):912-9. PubMed ID: 9062506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
    Forget H; Lacroix A; Bourdeau I; Cohen H
    Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
    Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis and management of Cushing's syndrome.
    Tsigos C; Chrousos GP
    Annu Rev Med; 1996; 47():443-61. PubMed ID: 8712794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total prostate-specific antigen assay in women with Cushing's disease or alcohol-dependent pseudo-Cushing's State.
    Coiro V; Volpi R; Galli P; Manfredi G; Magotti MG; Saccani-Jotti G; Chiodera P
    Horm Res; 2004; 61(3):148-52. PubMed ID: 14685016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy.
    Zeiger MA; Fraker DL; Pass HI; Nieman LK; Cutler GB; Chrousos GP; Norton JA
    Surgery; 1993 Dec; 114(6):1138-43. PubMed ID: 8256220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclic Cushing's Syndrome - rare or rarely recognized].
    Kiałka M; Doroszewska K; Mrozińska S; Milewicz T; Stochmal E
    Przegl Lek; 2015; 72(2):74-7. PubMed ID: 26727747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
    Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
    J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.